Research across Pneumonia
Related studies from across the Pneumonia family.
Questions about Community-Acquired Pneumonia
What are the risks of co-infection in children with HMPV and severe community-acquired pneumonia?
Co-infection, especially with Mycoplasma pneumoniae, is a significant risk factor for severe CAP in children with HMPV, with studies showing higher rates of co-infection in severe cases.
Full answer →Are children with severe community-acquired pneumonia more likely to have Mycoplasma pneumoniae?
Yes, children with severe community-acquired pneumonia are more likely to have Mycoplasma pneumoniae, with studies showing higher detection rates in severe cases.
Full answer →Can machine learning predict mortality better than APACHE-II for severe community-acquired pneumonia?
Yes, machine learning models, particularly GBDT and XGBoost, have outperformed APACHE-II in predicting mortality for severe community-acquired pneumonia with respiratory failure.
Full answer →What is the severe community-acquired pneumonia rate for children with HMPV?
In a recent study of hospitalized children with HMPV, 28.0% had severe community-acquired pneumonia (CAP).
Full answer →How does the severity of community-acquired pneumonia affect the detection of Mycoplasma pneumoniae in children?
Severe community-acquired pneumonia in children is associated with higher detection rates of Mycoplasma pneumoniae compared to non-severe cases, likely due to higher bacterial load and immune response.
Full answer →Does amoxicillin work just as well as other antibiotics for community-acquired pneumonia?
Current evidence suggests amoxicillin is generally as effective as other antibiotics for community-acquired pneumonia, but the choice depends on local resistance patterns and patient factors.
Full answer →